InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-46.5%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the detailed record of transactions filed by Doerfler Douglas, Chairman & CEO. Director active across 1 company, notably Maxcyte, INC.. In total, 11 disclosures have been recorded. Activity tracked since 12 November 2021. The latest transaction was filed on 4 December 2023 (Levée d'options). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Doerfler Douglas
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations11 total
25,008 shares@ US$0.0423.8% of flowCommon StockSEC:0001209191-23-057600:0
5,350 shares@ US$0.045.0% of flowCommon StockSEC:0001209191-23-057093:0
445 shares@ US$0.040.4% of flowCommon StockSEC:0001209191-23-042110:0
14,968 shares@ US$0.0414.4% of flowCommon StockSEC:0001209191-23-037358:0
16,149 shares@ US$0.0415.1% of flowCommon StockSEC:0001209191-23-027781:0
100 shares@ US$0.040.1% of flowCommon StockSEC:0001209191-23-024097:0
6,961 shares@ US$0.046.6% of flowCommon StockSEC:0001209191-23-023806:0
2,607 shares@ US$0.042.5% of flowCommon StockSEC:0001209191-23-022983:0
19,335 shares@ US$0.0418.4% of flowCommon StockSEC:0001209191-23-006876:0
10,613 shares@ US$0.0410.3% of flowCommon StockSEC:0001209191-23-001995:0
1,847 shares@ US$0.040.0001% mcap50.0% of flowCommon StockSEC:0001209191-21-064875:0
11 of 11 declarations
About Doerfler Douglas
Douglas Doerfler is the President and CEO of MaxCyte, Inc. He leads the company with a focus on innovation in biotechnology, developing solutions to enhance medical treatments.
